The Company offers consulting
service in the area of ADME and DMPK
Read moreservice in the area of ADME and DMPK
Mission of
Ungell ADME consulting AB is to secure:
Early detection of pharmacokinetic unwanted liabilities of the Lead/s or Candidate Drugs
Understanding of ADME properties securing Safe and Efficient Drugs to Humans
More than 30 Years in
Pharmaceutical Business
Biography
Anna-Lena Ungell received her PhD degree at the University of Gothenburg, Sweden. Her pharmaceutical business career and experiences started in the Pharmaceutical Unit and in the DMPK department in Discovery at AstraZeneca R&D between 1987 to 2013. In 2013 she moved to Belgium and started to work at UCB Biopharma sprl until 2020 and continued her career in the non-clinical DMPK part of New Medicines which later also included development up to life cycle management.
Read more